ELISA Testing Market By Application (Infectious Diseases, Cancer, Autoimmune Disorders, Allergy Testing, Endocrine Disorders, Immunology Research, Others) By Test Type (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Market Insights

• The global demand for ELISA Testing was valued at USD 2154.8 million in 2022 and is expected to reach USD 3758.07 million in 2030, growing at a CAGR of 7.20% between 2023 and 2030.
• Cancer is the leading segment by application.
• Direct ELISA is the leading segment by test type.
• During the projected period, the research institutes category is expected to increase at the greatest CAGR.
• The blood serum segment is predicted to register the greatest CAGR during the forecast period.
• During the forecast period, the segment of colorimetric ELISA is anticipated to have the greatest CAGR.
• North America dominated the ELISA Testing market.
• Europe is anticipated to be the second-largest region in the ELISA Testing market.
• The ELISA Testing market is expected to develop quickly in Asia Pacific.
• The market for ELISA Testing is expanding due to several factors, including an increased illness burden, the move towards personalized treatment, improvements in ELISA technology, the ability to detect cancer biomarkers, and awareness and preventive initiatives.

• The consistent need for diagnostic assessments, such as ELISA assays for infectious conditions, ELISA assays for food quality analysis, and ELISA-based studies in veterinary medicine to diagnose infectious diseases in animals, represents a few of the most significant market opportunities.

Executive Summary

Market Definition

The market for ELISA (Enzyme-Linked Immunosorbent Assay) testing refers to the global industry and market ecosystem focused on creating, manufacturing, and distributing diagnostic assays, kits, equipment, and ELISA-based services. In the fields of immunology and clinical diagnostics, ELISA is a widely used laboratory technique that is primarily used to identify and measure the concentration of specific antigens (proteins, peptides, hormones, antibodies, etc.) in a variety of biological samples, including blood, serum, plasma, urine, and tissue extracts.

Market Overview

The market for ELISA Testing has been expanding steadily in recent years, and between 2023 and 2030, it is anticipated to rise at a CAGR of 7.20%. The market was estimated to be worth USD 2154.8 million in 2022 and is anticipated to be worth USD 3758.07 million in 2030.

The global market for ELISA Testing is growing as a result of a number of factors, such as a growth in the incidence of illnesses, the shift to customized healthcare, advancements in ELISA innovation, the capacity to identify cancer biomarkers, and awareness and measures to prevent them. The worldwide struggle against diseases, including HIV/AIDS, TB, malaria, and other public health issues, opens prospects for ELISA-based diagnostics in resource-constrained regions.

The popularity of telehealth and remote medical services has raised demand for ELISA tests, which can be carried out and read remotely to enhance access to diagnostics. Adherence to legal requirements and quality control are essential in healthcare and diagnostics. Manufacturers make research and development investments to meet regulatory criteria and get required permits.

The market has grown due to key market participants making more advances. For instance, the Native Antigen Company announced the release of the NS1 enzyme-linked immunosorbent assay (ELISA) assay, a revolutionary Zika immunoassay, in 2019. This assay offers significant specificity and sensitivity across various biological materials. Thus, the market expanded as a result of these rapid advances.

Segmentation by Application

• The most popular application sector is cancer. In many areas of cancer diagnosis, prognosis, research, and treatment monitoring, ELISA (Enzyme-Linked Immunosorbent Assay) tests are used.
• The infectious diseases segment is anticipated to grow significantly during the projection period. For screening for HIV (Human Immunodeficiency Virus), ELISA is often used. It picks up antibodies the immune system makes in response to an HIV infection. Usually, Western blot or PCR are used as confirmatory assays after receiving a positive ELISA result.
• Other applications, such as autoimmune disorders, allergy testing, endocrine disorders, immunology research, and others, also contribute to the demand for ELISA Testing.

Segmentation by Test Type

• By test type, Direct ELISA is the dominant segment. An ELISA test known as a Direct ELISA (Enzyme-Linked Immunosorbent Assay) is used to identify and, in some cases, measure the concentration of a particular antigen in a sample. Compared to other ELISA variants like indirect ELISA or sandwich ELISA, it is a simple and reasonably quick assay with fewer stages.
• The indirect ELISA category is expected to grow significantly during the forecast period. Indirect ELISA is frequently used for various purposes, including serology (studying serum and antibodies), diagnostic procedures for infectious diseases, autoimmune disease diagnosis, vaccine development, and antibody screening in research and clinical laboratories.
• Other test types, such as sandwich ELISA and competitive ELISA, also contribute to the demand for ELISA Testing.

Segmentation by End-Users

• The market segment for research institutes is anticipated to experience the highest CAGR growth during the projected period. ELISA is widely used in immunology research to quantify antibody titers, cytokine profiles, and immunological responses. Researchers can evaluate how the immune system reacts to infections, vaccinations, or experimental drugs.
• Other end-users, such as hospitals and clinics, diagnostic laboratories, and pharmaceutical and biotechnology companies, also contribute to the demand for ELISA Testing.

Segmentation by Sample Type

• During the projection period, the blood serum segment is anticipated to have the highest CAGR. A blood serum ELISA test is a particular kind of ELISA test created to examine serum samples, which are the liquid component of blood following coagulation. Antibodies, antigens, hormones, proteins, and other biomolecules are among the numerous compounds in blood serum. Clinical diagnostics and research frequently use serum ELISA assays to identify and measure particular antigens or antibodies present in the serum.
• Other sample types, such as plasma, urine, saliva, cerebrospinal fluid, and different biological samples, also contribute to the demand for ELISA Testing.

Segmentation by Technology

• Colorimetric ELISA is predicted to have the highest CAGR during the anticipated timeframe. When a straightforward visual readout is sought, colorimetric ELISAs are frequently utilized. They have several uses, such as identifying particular proteins, antigens, antibodies, and enzymes in research, environmental testing, clinical diagnostics, and pharmaceutical quality control.
• Other technologies, such as fluorescence ELISA and chemiluminescence ELISA, also contribute to the demand for ELISA Testing.

Segmentation by Region

• The ELISA testing market is largely dominated by North America. The North American personalized medicine movement was driving the ELISA testing market. Specific biomarkers were measured by ELISA testing, which assisted clinicians in modifying treatment plans to meet the needs of various patients.
• It is anticipated that Europe will rank second in the global market for ELISA testing.
• In Asia Pacific, the ELISA Testing industry is anticipated to grow significantly.
• The rest of the demand for ELISA Testing is met by the rest of the world, which includes Latin America, the Middle East, and Africa.

The global demand for ELISA Testing is on the rise as a result of a wide range of variables, such as the rise in the incidence of illnesses, the shift to individualized healthcare, advancements in ELISA technology, the capacity to identify cancer biomarkers and a greater understanding and measures to avoid infection.

The North American region will dominate the ELISA Testing market throughout the forecast period. To enhance ELISA tests, researchers in North America were investigating cutting-edge technologies, including digital ELISA and microfluidic-based platforms. These innovations promised smaller sample sizes and increased sensitivity. To guarantee accurate and trustworthy results, healthcare practitioners and researchers in North America increasingly sought ELISA tests with enhanced sensitivity and specificity. Adopting POC testing technologies based on ELISA might have driven market expansion. POC ELISA tests provide quick findings, making them useful in clinical settings and environments with limited resources.

Asia Pacific is expected to increase fastest during the projection period. There may be a rising demand for ELISA tests for disease monitoring and management as non-communicable diseases like diabetes, cardiovascular diseases, and obesity continue to increase in Asia. Numerous Asia Pacific nations have experienced significant economic expansion and urbanization, which has increased healthcare spending and the availability of cutting-edge diagnostic tools like ELISA testing.

A significant opportunity exists for ELISA testing for pathogens like HIV, TB, hepatitis, and emerging illnesses in India due to the country’s issues with infectious diseases. There is an increasing need for quick and precise diagnostics to prevent outbreaks and manage conditions effectively.

India is a center for the creation of pharmaceuticals. For drug development, pharmacokinetics, and pharmacodynamics research, ELISA tests are useful instruments that open up new possibilities for collaboration and innovation.

Key Highlights of the Report

The global ELISA testing market is segmented by application, test type, end-users, sample type, technology, and region. Cancer is the foremost segment by application. The most used test type is direct ELISA. During the projected period, the category for research institutes is expected to increase at the greatest CAGR. North America is driving the ELISA testing market growth.

The ELISA testing market is expanding due to several factors, including the move towards personalized treatment, an increased illness burden, improvements in ELISA technology, the ability to detect cancer biomarkers, and awareness and preventive initiatives. The significant market prospects include the persistent demand for diagnostic tests, including ELISA assays, for infectious diseases, the use of ELISA assays in food safety investigation, and the use of ELISA-based assays in veterinary medicine to diagnose infectious diseases in animals.

However, North America is predicted to hold the largest market share for ELISA Testing globally. The adoption of ELISA-based POC testing technologies may have fueled market growth. Quick results from POC ELISA testing make them valuable in clinical settings and situations with constrained resources. Moreover, the market is anticipated to expand at the highest rate in the Asia-Pacific (APAC) region. As non-communicable diseases, including diabetes, cardiovascular conditions, and obesity, continue to rise throughout Asia, there may be a rising demand for ELISA testing for disease monitoring and management.

What Are the Main Factors Driving the ELISA Testing Market Globally?

The requirement for ELISA Testing continues to grow as a result of a number of factors, such as an upsurge in the number of illnesses, the shift to personalized medicine, advancements in ELISA technology, the capacity to identify cancer biomarkers, and general knowledge and preventive measures.

What Are The Main Challenges In The Global ELISA Testing Market?

The factors limiting the growth of the ELISA Testing market are high testing costs, complexity and labor-intensiveness, a lack of standardization, the emergence of substitute technologies, and cost containment in healthcare.

What Market Opportunities Exist For ELISA Testing Globally?

The increasing popularity of ELISA assays in food safety investigations, the ongoing demand for diagnostic tests, including ELISA assays, for infectious diseases, and the use of ELISA-based assays in veterinary medicine to diagnose infectious diseases in animals are some of the key market potential.

Market Drivers

Several factors influence the global market for ELISA Testing. The following are the main global market drivers for ELISA Testing:

ELISA Development Kits Are Receiving More R&D Funding.

The industry for ELISA testing may expand rapidly beause of rising R&D expenditure on ELISA (Enzyme-Linked Immunosorbent Assay) development kits. Innovating and developing new ELISA kits with improved sensitivity, specificity, and usability is made possible by increased R&D spending by corporations and educational organizations. The prospective applications of the ELISA test may be increased as a result of these discoveries, which may lead to the creation of new tests for detecting specific infections, diseases, or biomarkers. The development of biomarkers for numerous diseases, such as cancer, infectious diseases, autoimmune disorders, and more, uses ELISA kits extensively. The identification of novel biomarkers that can be used in ELISA kits for diagnosing or research purposes may come about as a result of improved R&D projects.

Therefore, expanded R&D spending on ELISA development kits promotes innovation and technological advancement, develops applications for ELISA testing, and makes it more affordable. As a result, it significantly contributes to the growth of the ELISA testing industry by satisfying the requirements of research and clinical testing.

Market Restraints

Several challenges may arise when the ELISA Testing sector expands globally. These are a few of them:

High Cost Of ELISA Tests

The market for ELISA testing may be restrained by the high price of ELISA (Enzyme-Linked Immunosorbent Assay) testing. When several analytes must be tested, or cutting-edge detection technologies are required, ELISA testing can be pricey. When resources are scarce, and healthcare budgets are tight, this expense may make them less accessible. As a result, ELISA-based diagnostics may not be widely available to patients and healthcare professionals in these areas. The adoption of ELISA testing may be slowed by high costs in emerging nations, with an increasing demand for accurate and affordable diagnostic options. Alternative, less expensive diagnostic techniques might be preferred in such areas, which could limit the market’s potential for growth.

Opportunities

The global industry offers multiple opportunities for ELISA Testing. One of these is demonstrated here:

Increasing Incidence Of Cancer

The ELISA (Enzyme-Linked Immunosorbent Assay) Testing market has much growth potential due to the rising incidence of cancer. The diagnosis, prognosis, and monitoring of cancer treatments all rely heavily on ELISA tests. Specific cancer biomarkers can be found in blood, serum, or other body fluids using ELISA assays. Early detection and screening initiatives are necessary as cancer incidence grows to detect the disease in its earliest, most curable stages. ELISA tests can be helpful in these initiatives, opening up chances for the market to grow. For people who have already been diagnosed with cancer, ELISA tests are used to track the development of the condition, evaluate the efficacy of treatment, and find recurrences. The need for these monitoring tests is rising as there are more cancer patients.

ELISA tests are utilized to investigate individual proteins involved in cancer pathways, identify potential therapeutic targets, and assess the effectiveness of targeted therapies. The need for ELISA assays grows as cancer biology and medication development research develops.

Competitive Landscape

Key Players

Many large companies are actively involved in the global ELISA Testing market. The top market participants and their corresponding market shares are listed in the list below:

• Danaher Corporation
• Quidel Corporation
• Ortho Clinical Diagnostics
• BioMérieux SA
• Bio-Rad Laboratories
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• Siemens Healthineers

To stay competitive, these businesses prioritize mergers and acquisitions, distribution channel development, and product innovation.

The top competitors in the global ELISA Testing market constantly seek to gain an advantage by releasing new products and innovations.

In September 2022, The second test in Neogen’s brand-new Veratox VIP family of enhanced quantitative ELISA tests, the Veratox VIP assay to detect cashews, was released by Neogen Corporation.

In September 2022, The HCV Gen 4 Ag & Ab Microlisa, a 4th Generation Elisa-based HCV Test, was introduced by J Mitra. The 4th Generation HCV Microlisa is a qualitative in-vitro enzyme-linked immunosorbent assay for identifying antibodies against HCV (anti-HCVs) and the HCV core antigen in human serum or plasma.

Summary of Key Findings

• The need for ELISA Testing is growing as a result of a range of variables, such as a growth in the number of ailments, the shift to personalized treatment, advancements in ELISA technology, the capacity to identify cancer biomarkers and public knowledge and prevention strategies.
• Market segmented by application, test type, end-users, sample type, technology, and region.
• The largest application segment is cancer.
• The market leader in terms of test type is direct ELISA.
• The category for research institutes is anticipated to experience the highest CAGR growth throughout the anticipated period.
• North America is leading market growth; the market is highly competitive with key players including Danaher Corporation, Quidel Corporation, Ortho Clinical Diagnostics, BioMérieux SA, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., Siemens Healthineers, and others.

Future Outlook

• Positive outlook for the global ELISA testing market with significant growth potential in the North American region.
• The ELISA testing industry is expanding as a result of the rising incidence of disease.
• During the projection period, high testing costs may provide a significant challenge to the market’s expansion.
• Major companies must concentrate on product innovation, expanding their market reach, and maintaining competitive pricing to stay ahead.

Segmentation

• By Application
  • Infectious Diseases
  • Cancer
  • Autoimmune Disorders
  • Allergy Testing
  • Endocrine Disorders
  • Immunology Research
  • Others
• By Test Type
  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA
• By End-Users
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical and Biotechnology Companies
• By Sample Type
  • Blood Serum
  • Plasma
  • Urine
  • Saliva
  • Cerebrospinal Fluid
  • Other Biological Samples
• By Technology
  • Colorimetric ELISA
  • Fluorescence ELISA
  • Chemiluminescence ELISA
• By Region
  • North America
    • The US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Adjacent Markets

The ELISA testing industry has several linked markets with high potential for revenue growth. The major markets adjacent to the ELISA testing market –

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

 

2. Executive Summary

2.1. Market Snapshot: Global ELISA Testing Market

2.1.1. Global ELISA Testing Market, By Application

2.1.2. Global ELISA Testing Market, By Test Type

2.1.3. Global ELISA Testing Market, By End-Users

2.1.4. Global ELISA Testing Market, By Sample Type

2.1.5. Global ELISA Testing Market, By Technology

2.1.6. Global ELISA Testing Market, By Region

2.2. Insights from Primary Respondents

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global ELISA Testing Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. ELISA Testing Market Drivers

3.2.2. ELISA Testing Market Restraints

3.2.3. ELISA Testing Market Opportunities

3.2.4. Major ELISA Testing Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Application

3.5.2. Test Type

3.5.3. End-Users

3.5.4. Sample Type

3.5.5. Technology

3.5.6. Geography

 

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global ELISA Testing Market: Company Market Share, Value 2022

4.1.2. Global ELISA Testing Market: Top 6 Company Market Share, Value 2022

4.1.3. Global ELISA Testing Market: Top 3 Company Market Share, Value 2022

4.2. Global ELISA Testing Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global ELISA Testing Market

 

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

 

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

 

7. Impact Analysis of COVID 19 and Russia – Ukraine War on ELISA Testing Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

 

8. Global ELISA Testing Market, By Application

8.1. Global ELISA Testing Market Overview, by Application

8.1.1. Global ELISA Testing Market Revenue Share, By Application, 2022 Vs 2030 (in %)

8.2. Infectious Diseases

8.2.1. Global ELISA Testing Market, By Infectious Diseases, By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for Infectious Diseases

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Cancer

8.3.1. Global ELISA Testing Market, By Cancer, By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for Cancer

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

8.4. Autoimmune Disorders

8.4.1. Global ELISA Testing Market, By Autoimmune Disorders, By Region, 2017-2030 (US$ Mn)

8.4.2. Market Dynamics for Autoimmune Disorders

8.4.2.1. Drivers

8.4.2.2. Restraints

8.4.2.3. Opportunities

8.4.2.4. Trends

8.5. Allergy Testing

8.5.1. Global ELISA Testing Market, By Allergy Testing, By Region, 2017-2030 (US$ Mn)

8.5.2. Market Dynamics for Allergy Testing

8.5.2.1. Drivers

8.5.2.2. Restraints

8.5.2.3. Opportunities

8.5.2.4. Trends

8.6. Endocrine Disorders

8.6.1. Global ELISA Testing Market, By Endocrine Disorders, By Region, 2017-2030 (US$ Mn)

8.6.2. Market Dynamics for Endocrine Disorders

8.6.2.1. Drivers

8.6.2.2. Restraints

8.6.2.3. Opportunities

8.6.2.4. Trends

8.7. Immunology Research

8.7.1. Global ELISA Testing Market, By Immunology Research, By Region, 2017-2030 (US$ Mn)

8.7.2. Market Dynamics for Immunology Research

8.7.2.1. Drivers

8.7.2.2. Restraints

8.7.2.3. Opportunities

8.7.2.4. Trends

8.8. Others

8.8.1. Global ELISA Testing Market, By Others, By Region, 2017-2030 (US$ Mn)

8.8.2. Market Dynamics for Others

8.8.2.1. Drivers

8.8.2.2. Restraints

8.8.2.3. Opportunities

8.8.2.4. Trends

 

9. Global ELISA Testing Market, By Test Type

9.1. Global ELISA Testing Market Overview, by Test Type

9.1.1. Global ELISA Testing Market Revenue Share, By Test Type, 2022 Vs 2030 (in %)

9.2. Direct ELISA

9.2.1. Global ELISA Testing Market, By Direct ELISA, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Direct ELISA

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Indirect ELISA

9.3.1. Global ELISA Testing Market, By Indirect ELISA, By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Indirect ELISA

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Sandwich ELISA

9.4.1. Global ELISA Testing Market, By Sandwich ELISA, By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Sandwich ELISA

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

9.5. Competitive ELISA

9.5.1. Global ELISA Testing Market, By Competitive ELISA, By Region, 2017-2030 (US$ Mn)

9.5.2. Market Dynamics for Competitive ELISA

9.5.2.1. Drivers

9.5.2.2. Restraints

9.5.2.3. Opportunities

9.5.2.4. Trends

 

10. Global ELISA Testing Market, By End-Users

10.1. Global ELISA Testing Market Overview, by End-Users

10.1.1. Global ELISA Testing Market Revenue Share, By End-Users, 2022 Vs 2030 (in %)

10.2. Hospitals and Clinics

10.2.1. Global ELISA Testing Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Hospitals and Clinics

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Diagnostic Laboratories

10.3.1. Global ELISA Testing Market, By Diagnostic Laboratories, By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Diagnostic Laboratories

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

10.4. Research Institutes

10.4.1. Global ELISA Testing Market, By Research Institutes, By Region, 2017-2030 (US$ Mn)

10.4.2. Market Dynamics for Research Institutes

10.4.2.1. Drivers

10.4.2.2. Restraints

10.4.2.3. Opportunities

10.4.2.4. Trends

10.5. Pharmaceutical and Biotechnology Companies

10.5.1. Global ELISA Testing Market, By Pharmaceutical and Biotechnology Companies, By Region, 2017-2030 (US$ Mn)

10.5.2. Market Dynamics for Pharmaceutical and Biotechnology Companies

10.5.2.1. Drivers

10.5.2.2. Restraints

10.5.2.3. Opportunities

10.5.2.4. Trends

 

11. Global ELISA Testing Market, By Sample Type

11.1. Global ELISA Testing Market Overview, by Sample Type

11.1.1. Global ELISA Testing Market Revenue Share, By Sample Type, 2022 Vs 2030 (in %)

11.2. Blood Serum

11.2.1. Global ELISA Testing Market, By Blood Serum, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Blood Serum

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Plasma

11.3.1. Global ELISA Testing Market, By Plasma, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Plasma

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

11.4. Urine

11.4.1. Global ELISA Testing Market, By Urine, By Region, 2017-2030 (US$ Mn)

11.4.2. Market Dynamics for Urine

11.4.2.1. Drivers

11.4.2.2. Restraints

11.4.2.3. Opportunities

11.4.2.4. Trends

11.5. Saliva

11.5.1. Global ELISA Testing Market, By Saliva, By Region, 2017-2030 (US$ Mn)

11.5.2. Market Dynamics for Saliva

11.5.2.1. Drivers

11.5.2.2. Restraints

11.5.2.3. Opportunities

11.5.2.4. Trends

11.6. Cerebrospinal Fluid

11.6.1. Global ELISA Testing Market, By Cerebrospinal Fluid, By Region, 2017-2030 (US$ Mn)

11.6.2. Market Dynamics for Cerebrospinal Fluid

11.6.2.1. Drivers

11.6.2.2. Restraints

11.6.2.3. Opportunities

11.6.2.4. Trends

11.7. Other Biological Samples

11.7.1. Global ELISA Testing Market, By Other Biological Samples, By Region, 2017-2030 (US$ Mn)

11.7.2. Market Dynamics for Other Biological Samples

11.7.2.1. Drivers

11.7.2.2. Restraints

11.7.2.3. Opportunities

11.7.2.4. Trends

 

12. Global ELISA Testing Market, By Technology

12.1. Global ELISA Testing Market Overview, by Technology

12.1.1. Global ELISA Testing Market Revenue Share, By Technology, 2022 Vs 2030 (in %)

12.2. Colorimetric ELISA

12.2.1. Global ELISA Testing Market, By Colorimetric ELISA, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Colorimetric ELISA

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Fluorescence ELISA

12.3.1. Global ELISA Testing Market, By Fluorescence ELISA, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for Fluorescence ELISA

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

12.4. Chemiluminescence ELISA

12.4.1. Global ELISA Testing Market, By Chemiluminescence ELISA, By Region, 2017-2030 (US$ Mn)

12.4.2. Market Dynamics for Chemiluminescence ELISA

12.4.2.1. Drivers

12.4.2.2. Restraints

12.4.2.3. Opportunities

12.4.2.4. Trends

 

13. Global ELISA Testing Market, By Region

13.1. Global ELISA Testing Market Overview, by Region

13.1.1. Global ELISA Testing Market, By Region, 2022 vs 2030 (in%)

13.2. Application

13.2.1. Global ELISA Testing Market, By Application, 2017-2030 (US$ Mn)

13.3. Test Type

13.3.1. Global ELISA Testing Market, By Test Type, 2017-2030 (US$ Mn)

13.4. End-Users

13.4.1. Global ELISA Testing Market, By End-Users, 2017-2030 (US$ Mn)

13.5. Sample Type

13.5.1. Global ELISA Testing Market, By Sample Type, 2017-2030 (US$ Mn)

13.6. Technology

13.6.1. Global ELISA Testing Market, By Technology, 2017-2030 (US$ Mn)

 

14. North America ELISA Testing Market Analysis

14.1. Overview

14.1.1. Market Dynamics for North America

14.1.1.1. Drivers

14.1.1.2. Restraints

14.1.1.3. Opportunities

14.1.1.4. Trends

14.2. North America ELISA Testing Market, by Application, 2017-2030(US$ Mn)

14.2.1. Overview

14.2.2. SRC Analysis

14.3. North America ELISA Testing Market, by Test Type, 2017-2030(US$ Mn)

14.3.1. Overview

14.3.2. SRC Analysis

14.4. North America ELISA Testing Market, by End-Users, 2017-2030(US$ Mn)

14.4.1. Overview

14.4.2. SRC Analysis

14.5. North America ELISA Testing Market, by Sample Type, 2017-2030(US$ Mn)

14.5.1. Overview

14.5.2. SRC Analysis

14.6. North America ELISA Testing Market, by Technology, 2017-2030(US$ Mn)

14.6.1. Overview

14.6.2. SRC Analysis

14.7. North America ELISA Testing Market, by Country, 2017-2030 (US$ Mn)

14.7.1. North America ELISA Testing Market, by Country, 2022 Vs 2030 (in%)

14.7.2. U.S.

14.7.3. Canada

14.7.4. Mexico

 

15. Europe ELISA Testing Market Analysis

15.1. Overview

15.1.1. Market Dynamics for Europe

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. Europe ELISA Testing Market, by Application, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. Europe ELISA Testing Market, by Test Type, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. Europe ELISA Testing Market, by End-Users, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. Europe ELISA Testing Market, by Sample Type, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. Europe ELISA Testing Market, by Technology, 2017-2030(US$ Mn)

15.6.1. Overview

15.6.2. SRC Analysis

15.7. Europe ELISA Testing Market, by Country, 2017-2030 (US$ Mn)

15.7.1. Europe ELISA Testing Market, by Country, 2022 Vs 2030 (in%)

15.7.2. UK

15.7.3. France

15.7.4. Germany

15.7.5. Italy

15.7.6. Spain

15.7.7. Benelux

15.7.8. Russia

15.7.9. Rest of Europe

 

16. Asia Pacific ELISA Testing Market Analysis

16.1. Overview

16.1.1. Market Dynamics for Asia Pacific

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Asia Pacific ELISA Testing Market, by Application, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Asia Pacific ELISA Testing Market, by Test Type, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Asia Pacific ELISA Testing Market, by End-Users, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Asia Pacific ELISA Testing Market, by Sample Type, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Asia Pacific ELISA Testing Market, by Technology, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. Asia Pacific ELISA Testing Market, by Country, 2017-2030 (US$ Mn)

16.7.1. Asia Pacific ELISA Testing Market, by Country, 2022 Vs 2030 (in%)

16.7.2. China

16.7.3. Japan

16.7.4. India

16.7.5. South Korea

16.7.6. South East Asia

16.7.7. Rest of Asia Pacific

 

17. Latin America ELISA Testing Market Analysis

17.1. Overview

17.1.1. Market Dynamics for Latin America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Latin America ELISA Testing Market, by Application, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Latin America ELISA Testing Market, by Test Type, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Latin America ELISA Testing Market, by End-Users, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Latin America ELISA Testing Market, by Sample Type, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Latin America ELISA Testing Market, by Technology, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Latin America ELISA Testing Market, by Country, 2017-2030 (US$ Mn)

17.7.1. Latin America ELISA Testing Market, by Country, 2022 Vs 2030 (in%)

17.7.2. Brazil

17.7.3. Argentina

17.7.4. Rest of Latin America

 

18. Middle East ELISA Testing Market Analysis

18.1. Overview

18.1.1. Market Dynamics for Middle East

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Middle East ELISA Testing Market, by Application, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Middle East ELISA Testing Market, by Test Type, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Middle East ELISA Testing Market, by End-Users, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Middle East ELISA Testing Market, by Sample Type, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Middle East ELISA Testing Market, by Technology, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Middle East ELISA Testing Market, by Country, 2017-2030 (US$ Mn)

18.7.1. Middle East ELISA Testing Market, by Country, 2022 Vs 2030 (in%)

18.7.2. UAE

18.7.3. Saudi Arabia

18.7.4. Rest of Middle East

 

19. Africa ELISA Testing Market Analysis

19.1. Overview

19.1.1. Market Dynamics for Africa

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Africa ELISA Testing Market, by Application, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Africa ELISA Testing Market, by Test Type, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Africa ELISA Testing Market, by End-Users, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Africa ELISA Testing Market, by Sample Type, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Africa ELISA Testing Market, by Technology, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Africa ELISA Testing Market, by Country, 2017-2030 (US$ Mn)

19.7.1. Africa ELISA Testing Market, by Country, 2022 Vs 2030 (in%)

19.7.2. South Africa

19.7.3. Egypt

19.7.4. Rest of Africa

 

20. Company Profiles

20.1. Danaher Corporation

20.1.1. Company Overview

20.1.2. Products/Services Portfolio

20.1.3. Geographical Presence

20.1.4. SWOT Analysis

20.1.5. Financial Summary

20.1.5.1. Market Revenue and Net Profit (2019-2022)

20.1.5.2. Business Segment Revenue Analysis

20.1.5.3. Geographical Revenue Analysis

20.2. Quidel Corporation

20.3. Ortho Clinical Diagnostics

20.4. BioMérieux SA

20.5. Bio-Rad Laboratories

20.6. Abbott Laboratories

20.7. F. Hoffmann-La Roche AG

20.8. Sysmex Corporation

20.9. Thermo Fisher Scientific, Inc.

20.10. Siemens Healthineers

20.11. Others

 

21. Research Methodology

21.1. Research Methodology

21.2. Phase I – Secondary Research

21.3. Phase II – Data Modelling

21.3.1. Company Share Analysis Model

21.3.2. Revenue Based Modelling

21.4. Phase III – Primary Research

21.5. Research Limitations

21.5.1. Assumptions

List of Figures

FIG. 1 Global ELISA Testing Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global ELISA Testing Market Segmentation

FIG. 4 Global ELISA Testing Market, by Application, 2022 (US$ Mn)

FIG. 5 Global ELISA Testing Market, by Test Type, 2022 (US$ Mn)

FIG. 6 Global ELISA Testing Market, by End-Users, 2022 (US$ Mn)

FIG. 7 Global ELISA Testing Market, by Sample Type, 2022 (US$ Mn)

FIG. 8 Global ELISA Testing Market, by Technology, 2022 (US$ Mn)

FIG. 9 Global ELISA Testing Market, by Geography, 2022 (US$ Mn)

FIG. 10 Attractive Investment Proposition, by Application, 2022

FIG. 11 Attractive Investment Proposition, by Test Type, 2022

FIG. 12 Attractive Investment Proposition, by End-Users, 2022

FIG. 13 Attractive Investment Proposition, by Sample Type, 2022

FIG. 14 Attractive Investment Proposition, by Technology, 2022

FIG. 15 Attractive Investment Proposition, by Geography, 2022

FIG. 16 Global Market Share Analysis of Key ELISA Testing Market Manufacturers, 2022

FIG. 17 Global Market Positioning of Key ELISA Testing Market Manufacturers, 2022

FIG. 18 Global ELISA Testing Market Value Contribution, By Application, 2022 & 2030 (Value %)

FIG. 19 Global ELISA Testing Market, by Infectious Diseases, Value, 2017-2030 (US$ Mn)

FIG. 20 Global ELISA Testing Market, by Cancer, Value, 2017-2030 (US$ Mn)

FIG. 21 Global ELISA Testing Market, by Autoimmune Disorders, Value, 2017-2030 (US$ Mn)

FIG. 22 Global ELISA Testing Market, by Allergy Testing, Value, 2017-2030 (US$ Mn)

FIG. 23 Global ELISA Testing Market, by Endocrine Disorders, Value, 2017-2030 (US$ Mn)

FIG. 24 Global ELISA Testing Market, by Immunology Research, Value, 2017-2030 (US$ Mn)

FIG. 25 Global ELISA Testing Market, by Others, Value, 2017-2030 (US$ Mn)

FIG. 26 Global ELISA Testing Market Value Contribution, By Test Type, 2022 & 2030 (Value %)

FIG. 27 Global ELISA Testing Market, by Direct ELISA, Value, 2017-2030 (US$ Mn)

FIG. 28 Global ELISA Testing Market, by Indirect ELISA, Value, 2017-2030 (US$ Mn)

FIG. 29 Global ELISA Testing Market, by Sandwich ELISA, Value, 2017-2030 (US$ Mn)

FIG. 30 Global ELISA Testing Market, by Competitive ELISA, Value, 2017-2030 (US$ Mn)

FIG. 31 Global ELISA Testing Market Value Contribution, By End-Users, 2022 & 2030 (Value %)

FIG. 32 Global ELISA Testing Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)

FIG. 33 Global ELISA Testing Market, by Diagnostic Laboratories, Value, 2017-2030 (US$ Mn)

FIG. 34 Global ELISA Testing Market, by Research Institutes, Value, 2017-2030 (US$ Mn)

FIG. 35 Global ELISA Testing Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Mn)

FIG. 36 Global ELISA Testing Market Value Contribution, By Sample Type, 2022 & 2030 (Value %)

FIG. 37 Global ELISA Testing Market, by Blood Serum, Value, 2017-2030 (US$ Mn)

FIG. 38 Global ELISA Testing Market, by Plasma, Value, 2017-2030 (US$ Mn)

FIG. 39 Global ELISA Testing Market, by Urine, Value, 2017-2030 (US$ Mn)

FIG. 40 Global ELISA Testing Market, by Saliva, Value, 2017-2030 (US$ Mn)

FIG. 41 Global ELISA Testing Market, by Cerebrospinal Fluid, Value, 2017-2030 (US$ Mn)

FIG. 42 Global ELISA Testing Market, by Other Biological Samples, Value, 2017-2030 (US$ Mn)

FIG. 43 Global ELISA Testing Market Value Contribution, By Technology, 2022 & 2030 (Value %)

FIG. 44 Global ELISA Testing Market, by Colorimetric ELISA, Value, 2017-2030 (US$ Mn)

FIG. 45 Global ELISA Testing Market, by Fluorescence ELISA, Value, 2017-2030 (US$ Mn)

FIG. 46 Global ELISA Testing Market, by Chemiluminescence ELISA, Value, 2017-2030 (US$ Mn)

FIG. 47 North America ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 48 U.S. ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 49 Canada ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 50 Mexico ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 51 Europe ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 52 Germany ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 53 France ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 54 U.K. ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 55 Italy ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 56 Spain ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 57 Benelux ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 58 Russia ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 59 Rest of Europe ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 60 Asia Pacific ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 61 China ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 62 Japan ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 63 India ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 64 South Korea ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 65 South-East Asia ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 66 Rest of Asia Pacific ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 67 Latin America ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 68 Brazil ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 69 Argentina ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 70 Rest of Latin America ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 71 Middle East ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 72 UAE ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 73 Saudi Arabia ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 74 Rest of Middle East ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 75 Africa ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 76 South Africa ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 77 Egypt ELISA Testing Market, 2017-2030 (US$ Mn)

FIG. 78 Rest of Africa ELISA Testing Market, 2017-2030 (US$ Mn)

 

List of Tables

TABLE 1 Market Snapshot: Global ELISA Testing Market

TABLE 2 Global ELISA Testing Market: Market Drivers Impact Analysis

TABLE 3 Global ELISA Testing Market: Market Restraints Impact Analysis

TABLE 4 Global ELISA Testing Market, by Competitive Benchmarking, 2022

TABLE 5 Global ELISA Testing Market, by Geographical Presence Analysis, 2022

TABLE 6 Global ELISA Testing Market, by Key Strategies Analysis, 2022

TABLE 7 Global ELISA Testing Market, by Infectious Diseases, By Region, 2017-2022 (US$ Mn)

TABLE 8 Global ELISA Testing Market, by Infectious Diseases, By Region, 2023-2030 (US$ Mn)

TABLE 9 Global ELISA Testing Market, by Cancer, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global ELISA Testing Market, by Cancer, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global ELISA Testing Market, by Autoimmune Disorders, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global ELISA Testing Market, by Autoimmune Disorders, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global ELISA Testing Market, by Allergy Testing, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global ELISA Testing Market, by Allergy Testing, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global ELISA Testing Market, by Endocrine Disorders, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global ELISA Testing Market, by Endocrine Disorders, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global ELISA Testing Market, by Immunology Research, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global ELISA Testing Market, by Immunology Research, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global ELISA Testing Market, by Others, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global ELISA Testing Market, by Others, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global ELISA Testing Market, by Direct ELISA, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global ELISA Testing Market, by Direct ELISA, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global ELISA Testing Market, by Indirect ELISA, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global ELISA Testing Market, by Indirect ELISA, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global ELISA Testing Market, by Sandwich ELISA, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global ELISA Testing Market, by Sandwich ELISA, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global ELISA Testing Market, by Competitive ELISA, By Region, 2017-2022 (US$ Mn)

TABLE 28 Global ELISA Testing Market, by Competitive ELISA, By Region, 2023-2030 (US$ Mn)

TABLE 29 Global ELISA Testing Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)

TABLE 30 Global ELISA Testing Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)

TABLE 31 Global ELISA Testing Market, by Diagnostic Laboratories, By Region, 2017-2022 (US$ Mn)

TABLE 32 Global ELISA Testing Market, by Diagnostic Laboratories, By Region, 2023-2030 (US$ Mn)

TABLE 33 Global ELISA Testing Market, by Research Institutes, By Region, 2017-2022 (US$ Mn)

TABLE 34 Global ELISA Testing Market, by Research Institutes, By Region, 2023-2030 (US$ Mn)

TABLE 35 Global ELISA Testing Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Mn)

TABLE 36 Global ELISA Testing Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Mn)

TABLE 37 Global ELISA Testing Market, by Blood Serum, By Region, 2017-2022 (US$ Mn)

TABLE 38 Global ELISA Testing Market, by Blood Serum, By Region, 2023-2030 (US$ Mn)

TABLE 39 Global ELISA Testing Market, by Plasma, By Region, 2017-2022 (US$ Mn)

TABLE 40 Global ELISA Testing Market, by Plasma, By Region, 2023-2030 (US$ Mn)

TABLE 41 Global ELISA Testing Market, by Urine, By Region, 2017-2022 (US$ Mn)

TABLE 42 Global ELISA Testing Market, by Urine, By Region, 2023-2030 (US$ Mn)

TABLE 43 Global ELISA Testing Market, by Saliva, By Region, 2017-2022 (US$ Mn)

TABLE 44 Global ELISA Testing Market, by Saliva, By Region, 2023-2030 (US$ Mn)

TABLE 45 Global ELISA Testing Market, by Cerebrospinal Fluid, By Region, 2017-2022 (US$ Mn)

TABLE 46 Global ELISA Testing Market, by Cerebrospinal Fluid, By Region, 2023-2030 (US$ Mn)

TABLE 47 Global ELISA Testing Market, by Other Biological Samples, By Region, 2017-2022 (US$ Mn)

TABLE 48 Global ELISA Testing Market, by Other Biological Samples, By Region, 2023-2030 (US$ Mn)

TABLE 49 Global ELISA Testing Market, by Colorimetric ELISA, By Region, 2017-2022 (US$ Mn)

TABLE 50 Global ELISA Testing Market, by Colorimetric ELISA, By Region, 2023-2030 (US$ Mn)

TABLE 51 Global ELISA Testing Market, by Fluorescence ELISA, By Region, 2017-2022 (US$ Mn)

TABLE 52 Global ELISA Testing Market, by Fluorescence ELISA, By Region, 2023-2030 (US$ Mn)

TABLE 53 Global ELISA Testing Market, by Chemiluminescence ELISA, By Region, 2017-2022 (US$ Mn)

TABLE 54 Global ELISA Testing Market, by Chemiluminescence ELISA, By Region, 2023-2030 (US$ Mn)

TABLE 55 Global ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 56 Global ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 57 Global ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 58 Global ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 59 Global ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 60 Global ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 61 Global ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 62 Global ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 63 Global ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 64 Global ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 65 Global ELISA Testing Market, by Region, 2017-2022 (US$ Mn)

TABLE 66 Global ELISA Testing Market, by Region, 2023-2030 (US$ Mn)

TABLE 67 North America ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 68 North America ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 69 North America ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 70 North America ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 71 North America ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 72 North America ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 73 North America ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 74 North America ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 75 North America ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 76 North America ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 77 North America ELISA Testing Market, by Country, 2017-2022 (US$ Mn)

TABLE 78 North America ELISA Testing Market, by Country, 2023-2030 (US$ Mn)

TABLE 79 United States ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 80 United States ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 81 United States ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 82 United States ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 83 United States ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 84 United States ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 85 United States ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 86 United States ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 87 United States ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 88 United States ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 89 Canada ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 90 Canada ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 91 Canada ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 92 Canada ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 93 Canada ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 94 Canada ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 95 Canada ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 96 Canada ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 97 Canada ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 98 Canada ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 99 Mexico ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 100 Mexico ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 101 Mexico ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 102 Mexico ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 103 Mexico ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 104 Mexico ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 105 Mexico ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 106 Mexico ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 107 Mexico ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 108 Mexico ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 109 Europe ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 110 Europe ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 111 Europe ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 112 Europe ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 113 Europe ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 114 Europe ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 115 Europe ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 116 Europe ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 117 Europe ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 118 Europe ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 119 Europe ELISA Testing Market, by Country, 2017-2022 (US$ Mn)

TABLE 120 Europe ELISA Testing Market, by Country, 2023-2030 (US$ Mn)

TABLE 121 Germany ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 122 Germany ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 123 Germany ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 124 Germany ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 125 Germany ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 126 Germany ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 127 Germany ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 128 Germany ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 129 Germany ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 130 Germany ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 131 France ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 132 France ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 133 France ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 134 France ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 135 France ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 136 France ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 137 France ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 138 France ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 139 France ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 140 France ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 141 United Kingdom ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 142 United Kingdom ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 143 United Kingdom ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 144 United Kingdom ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 145 United Kingdom ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 146 United Kingdom ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 147 United Kingdom ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 148 United Kingdom ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 149 United Kingdom ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 150 United Kingdom ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 151 Italy ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 152 Italy ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 153 Italy ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 154 Italy ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 155 Italy ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 156 Italy ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 157 Italy ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 158 Italy ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 159 Italy ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 160 Italy ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 161 Spain ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 162 Spain ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 163 Spain ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 164 Spain ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 165 Spain ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 166 Spain ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 167 Spain ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 168 Spain ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 169 Spain ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 170 Spain ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 171 Benelux ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 172 Benelux ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 173 Benelux ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 174 Benelux ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 175 Benelux ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 176 Benelux ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 177 Benelux ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 178 Benelux ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 179 Benelux ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 180 Benelux ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 181 Russia ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 182 Russia ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 183 Russia ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 184 Russia ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 185 Russia ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 186 Russia ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 187 Russia ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 188 Russia ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 189 Russia ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 190 Russia ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 191 Rest of Europe ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 192 Rest of Europe ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 193 Rest of Europe ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 194 Rest of Europe ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 195 Rest of Europe ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 196 Rest of Europe ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 197 Rest of Europe ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 198 Rest of Europe ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 199 Rest of Europe ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 200 Rest of Europe ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 201 Asia Pacific ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 202 Asia Pacific ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 203 Asia Pacific ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 204 Asia Pacific ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 205 Asia Pacific ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 206 Asia Pacific ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 207 Asia Pacific ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 208 Asia Pacific ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 209 Asia Pacific ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 210 Asia Pacific ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 211 China ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 212 China ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 213 China ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 214 China ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 215 China ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 216 China ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 217 China ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 218 China ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 219 China ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 220 China ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 221 Japan ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 222 Japan ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 223 Japan ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 224 Japan ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 225 Japan ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 226 Japan ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 227 Japan ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 228 Japan ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 229 Japan ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 230 Japan ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 231 India ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 232 India ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 233 India ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 234 India ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 235 India ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 236 India ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 237 India ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 238 India ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 239 India ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 240 India ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 241 South Korea ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 242 South Korea ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 243 South Korea ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 244 South Korea ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 245 South Korea ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 246 South Korea ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 247 South Korea ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 248 South Korea ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 249 South Korea ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 250 South Korea ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 251 South-East Asia ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 252 South-East Asia ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 253 South-East Asia ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 254 South-East Asia ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 255 South-East Asia ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 256 South-East Asia ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 257 South-East Asia ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 258 South-East Asia ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 259 South-East Asia ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 260 South-East Asia ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 261 Rest of Asia Pacific ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 262 Rest of Asia Pacific ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 263 Rest of Asia Pacific ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 264 Rest of Asia Pacific ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 265 Rest of Asia Pacific ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 266 Rest of Asia Pacific ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 267 Rest of Asia Pacific ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 268 Rest of Asia Pacific ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 269 Rest of Asia Pacific ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 270 Rest of Asia Pacific ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 271 Latin America ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 272 Latin America ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 273 Latin America ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 274 Latin America ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 275 Latin America ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 276 Latin America ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 277 Latin America ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 278 Latin America ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 279 Latin America ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 280 Latin America ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 281 Brazil ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 282 Brazil ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 283 Brazil ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 284 Brazil ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 285 Brazil ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 286 Brazil ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 287 Brazil ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 288 Brazil ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 289 Brazil ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 290 Brazil ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 291 Argentina ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 292 Argentina ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 293 Argentina ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 294 Argentina ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 295 Argentina ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 296 Argentina ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 297 Argentina ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 298 Argentina ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 299 Argentina ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 300 Argentina ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 301 Rest of Latin America ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 302 Rest of Latin America ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 303 Rest of Latin America ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 304 Rest of Latin America ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 305 Rest of Latin America ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 306 Rest of Latin America ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 307 Rest of Latin America ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 308 Rest of Latin America ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 309 Rest of Latin America ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 310 Rest of Latin America ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 311 Middle East ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 312 Middle East ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 313 Middle East ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 314 Middle East ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 315 Middle East ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 316 Middle East ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 317 Middle East ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 318 Middle East ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 319 Middle East ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 320 Middle East ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 321 UAE ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 322 UAE ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 323 UAE ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 324 UAE ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 325 UAE ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 326 UAE ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 327 UAE ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 328 UAE ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 329 UAE ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 330 UAE ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 331 Saudi Arabia ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 332 Saudi Arabia ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 333 Saudi Arabia ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 334 Saudi Arabia ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 335 Saudi Arabia ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 336 Saudi Arabia ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 337 Saudi Arabia ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 338 Saudi Arabia ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 339 Saudi Arabia ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 340 Saudi Arabia ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 341 Rest of Middle East ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 342 Rest of Middle East ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 343 Rest of Middle East ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 344 Rest of Middle East ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 345 Rest of Middle East ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 346 Rest of Middle East ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 347 Rest of Middle East ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 348 Rest of Middle East ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 349 Rest of Middle East ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 350 Rest of Middle East ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 351 Africa ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 352 Africa ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 353 Africa ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 354 Africa ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 355 Africa ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 356 Africa ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 357 Africa ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 358 Africa ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 359 Africa ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 360 Africa ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 361 South Africa ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 362 South Africa ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 363 South Africa ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 364 South Africa ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 365 South Africa ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 366 South Africa ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 367 South Africa ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 368 South Africa ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 369 South Africa ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 370 South Africa ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 371 Egypt ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 372 Egypt ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 373 Egypt ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 374 Egypt ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 375 Egypt ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 376 Egypt ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 377 Egypt ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 378 Egypt ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 379 Egypt ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 380 Egypt ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)

TABLE 381 Rest of Africa ELISA Testing Market, by Application, 2017-2022 (US$ Mn)

TABLE 382 Rest of Africa ELISA Testing Market, by Application, 2023-2030 (US$ Mn)

TABLE 383 Rest of Africa ELISA Testing Market, by Test Type, 2017-2022 (US$ Mn)

TABLE 384 Rest of Africa ELISA Testing Market, by Test Type, 2023-2030 (US$ Mn)

TABLE 385 Rest of Africa ELISA Testing Market, by End-Users, 2017-2022 (US$ Mn)

TABLE 386 Rest of Africa ELISA Testing Market, by End-Users, 2023-2030 (US$ Mn)

TABLE 387 Rest of Africa ELISA Testing Market, by Sample Type, By Region, 2017-2022 (US$ Mn)

TABLE 388 Rest of Africa ELISA Testing Market, by Sample Type, By Region, 2023-2030 (US$ Mn)

TABLE 389 Rest of Africa ELISA Testing Market, by Technology, 2017-2022 (US$ Mn)

TABLE 390 Rest of Africa ELISA Testing Market, by Technology, 2023-2030 (US$ Mn)